CEACAM5 and pancreatic intraductal papillary-mucinous neoplasm: Only CEA>41 ng/mL showed comparable sensitivity for IPMN (71%) and mPCN (73%) as GNAS (70% and 65%, respectively) but lower specificity than CEA>192 ng/mL.